+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Next-Generation Antibody Therapeutics Global Market Report 2024 - Product Thumbnail Image

Next-Generation Antibody Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • May 2019
  • 480 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Biologics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Biologics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Retinal Vein Occlusion - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Retinal Vein Occlusion - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 174 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Macular Degeneration Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Macular Degeneration Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 250 Pages
  • Global
Retinopathy of Prematurity - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Retinopathy of Prematurity - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 113 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 847 Pages
  • Global
From
Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024 - Product Thumbnail Image

Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Convalescent Plasma Therapy Global Market Report 2024 - Product Thumbnail Image

Convalescent Plasma Therapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 50 Pages
  • Global
From
Rheumatoid Arthritis Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 52 Pages
  • Global
From
COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

  • Report
  • September 2021
  • 52 Pages
  • Global
From
Loading Indicator